Alvotech revenue breakdown overview

Alvotech revenue for the last year amounted to 93.40 M USD, the most of which — 91.43 M USD — came from its highest performing source at the moment, Biosimilar Medicines, the year earlier bringing 83.03 M USD. The greatest contribution to the revenue figure was made by Europe — last year it brought Alvotech 63.51 M USD, and the year before that — 39.43 M USD.